Latest Insider Positions

SNYDERMAN RALPH is listed as an insider in the following companies: CDNA / CareDx, Inc. IRTC / iRhythm Technologies, Inc. PGND / Press Ganey Holdings, Inc. ARGS / Argos Therapeutics, Inc. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.


Security Title Post Shares
IRTC / iRhythm Technologies Director 3,142
CDNA / CareDx Director 63,799
ARGS / Argos Therapeutics Director 573
PGND / Press Ganey Holdings Director 0

Latest Transactions

Tran Date
Security Code Shares Post Shares Percent
2018-05-23 IRTC / iRhythm Technologies A 1,193 3,142 61.21
2018-04-02 CDNA / CareDx A 2,221 63,799 3.61
2018-01-02 CDNA / CareDx A 1,924 61,578 3.23
2017-10-02 CDNA / CareDx A 5,713 59,654 10.59
2017-07-17 IRTC / iRhythm Technologies A 1,949 1,949
2017-07-13 CDNA / CareDx A 5,000 53,941 10.22
2017-07-03 CDNA / CareDx A 7,534 48,941 18.19
2017-04-01 CDNA / CareDx A 5,384 41,407 14.95
2017-01-01 CDNA / CareDx A 3,463 36,023 10.64
2016-12-31 ARGS / Argos Therapeutics A 573 573
2016-10-21 PGND / Press Ganey Holdings D -28,770 0 -100.00 40.50 -1,165,185
2016-10-01 CDNA / CareDx A 2,614 32,560 8.73
2016-07-15 CDNA / CareDx A 5,000 29,946 20.04
2016-07-01 CDNA / CareDx A 1,653 24,946 7.10
2016-06-21 PGND / Press Ganey Holdings A 3,402 28,770 13.41
2016-04-01 CDNA / CareDx A 2,247 23,293 10.68
2016-01-01 CDNA / CareDx A 2,112 21,046 11.15
2015-10-01 CDNA / CareDx A 1,739 18,934 10.11
2015-07-01 CDNA / CareDx A 2,117 17,195 14.04
2015-05-21 PGND / Press Ganey Holdings A 5,000 25,368 24.55
2015-04-22 CDNA / CareDx M 11,678 15,078 343.47 2.329 27,198
2015-04-01 CDNA / CareDx A 1,440 3,400 73.47
Open market or private purchase of non-derivative or derivative security
Open market or private sale of non-derivative or derivative security
Grant, award, or other acquisition of securities from the company (such as an option)
Conversion of derivative
Sale or transfer of securities back to the company
Payment of exercise price or tax liability using portion of securities received from the company
Gift of securities by or to the insider
Equity swaps and similar hedging transactions
Exercise or conversion of derivative security received from the company (such as an option)
A transaction voluntarily reported on Form 4
Other (accompanied by a footnote describing the transaction)

Peers of SNYDERMAN RALPH include the following: ALLEN LEE F MD PhD, Abbey Jeffrey D, Anderson Devin J, Aynechi Tiba, BYERS BROOK H, Bairey Merz Cathleen Noel, Bell Michael Brian, Bickerstaff George, Birner Hubert, Bodaken Bruce G., Carey Robert, Chambon Philippe O., Cmielewski Patricia, Cohen Fred E, Constanti Charles, Costello David J., Crowe Jeffrey, DRISCOLL JOHN PATRICK, DeFonzo Joshua, Delagardelle Jeani, FEIGH BREHT T, ForArgos B.V., GAGNON NEIL, Garrett Matthew C., Glaser John P, Goldberg Michael, Greskoviak Joseph P, HAGSTROM WILLIAM A, HAQUE PROMOD, HUNT RONALD, Hallgren Matthew, Harrelson Lori R., Howard Matthew D., Jain Mudit K., Karlsson Anders, Katz Richard D, King Kevin M, King Sasha, Krol Igor, LUDLUM KEN, Lamarre Jean, Lathi Vijay K, MIESOWICZ FREDERICK, MILLER DOUGLAS S, MORRISON RICHARD G, Maag Peter, Meyer Matthew J., Midroc Invest AB, Mtibelishvily Irackly, Nelles Mitchell J, New Leaf Venture Associates II, L.P., New Leaf Venture Management II, L.L.C., New Leaf Ventures II, L.P., Nicolette Charles A., Norwalk Leslie V, Norwest Venture Partners XI, LP, Norwest Venture Partners XII, LP, Novo A/S, OCONNELL DANIEL S, Petrov Andrei Vladimirovich, Pharmstandard International S.A., Plessinger Douglas C., Public Joint Stock Co Pharmstandard, ROTH GREG, RUBASH MARK J, Ratcliffe Liam, Riskind Patricia L., Ryan Patrick T, SYNERGY LIFE SCIENCE PARTNERS L P, Scott Raymond W., Sninsky John Joseph, Stack Richard S., Starling William N JR, Sung Derrick, Suvarna Suda, Synergy Venture Partners, LLC, TALWALKAR ABHIJIT Y, Underdown Brian J., VESTAR ASSOCIATES V, L.P., VESTAR MANAGERS V LTD., Van Holle Philippe Marie Marcel Joseph, Vestar Capital Partners V A L P, Vestar Capital Partners V L P, Vestar Capital Partners V-B LP, Vestar Co-Invest V, L.P., Vestar Executives V LP, Vestar Investors V, L.P., Vestar/PGA Investors, LLC, Vinogradov Alexey Alexandrovich, Vort David A, Whitson Todd, Winterbottom Joan, Yee James P, Zane Ellen M, de Clercq Casper L., van Deventer Sander, . Peers are determined by cross-linking the filings of SNYDERMAN RALPH with insider filings of others at the same companies.

Related News Stories

iRhythm Technologies' (IRTC) CEO Kevin King on Q1 2018 Results - Earnings Call Transcript

2018-05-05 seekingalpha
Good afternoon, ladies and gentlemen, and welcome to the iRhythm Technologies Inc. Q1 2018 Earnings Conference Call. [Operator Instructions] As a reminder, the conference is being recorded. (13-0)

iRhythm Technologies' (IRTC) CEO Kevin King on Q4 2017 Results - Earnings Call Transcript

2018-02-15 seekingalpha
Good day, ladies and gentlemen, and welcome to the iRhythm Technologies Q4 2017 Earnings Conference Call. [Operator Instructions]. As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Lynn Lewis, Investor Relations. You may begin. (1-0)

iRhythm Technologies Is In A Good Business - Cramer's Lightning Round (1/10/18)

2018-01-11 seekingalpha
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, January 10. (16-0)

Cramer's lightning round: General Dynamics is about to move higher

2018-01-10 cnbc
General Dynamics Corporation: "Look, we can sell and buy Scotts Miracle-Gro, but I actually prefer General Dynamics. General Dynamics, Raytheon and Lockheed Martin, they are all for me. I think you've got a good one. Let's wait. It's about to have another move. That's how it trades: in fits and starts." (17-0)